https://pharmamedic.co/resources/white-paper/2020-02-18T12:32:53+00:00https://pharmamedic.co/news/general/drug-price-transparency-dont-play-the-blame-game/2020-02-05T10:54:46+00:00https://pharmamedic.co/news/general/why-working-with-an-outsourced-medical-affairs-team-may-provide-a-perfect-solution/2020-03-09T16:43:43+00:00https://pharmamedic.co/news/general/pharmamedics-covid-19-resource-round-up/2020-03-24T08:23:11+00:00https://pharmamedic.co/news/general/a-deeper-dive-into-pharmamedics-virtualpharma-solution/2020-04-15T12:19:51+01:00https://pharmamedic.co/news/general/thriving-in-a-time-of-covid-19-the-skills-consultants-need-now-more-than-ever/2020-05-05T16:15:44+01:00https://pharmamedic.co/news/general/applications-and-opportunities-of-artificial-intelligence-in-clinical-decision-making/2021-03-08T12:45:26+00:00https://pharmamedic.co/news/general/is-covid-19-ushering-in-an-era-of-renewed-pragmatism-in-medicine/2020-06-10T16:33:30+01:00https://pharmamedic.co/news/general/what-is-it-like-working-as-a-pharmamedic-consultant/2021-03-08T12:46:24+00:00https://pharmamedic.co/news/general/consultant-series-qa-with-sarah-hollywood/2021-03-08T12:46:01+00:00https://pharmamedic.co/news/general/to-succeed-with-a-marketing-authorisation-extension-or-variation-it-is-essential-that-regulatory-and-medical-affairs-teams-work-hand-in-hand/2020-07-28T08:35:30+01:00https://pharmamedic.co/news/general/client-qa-olivia-marsh-glenmark-pharmaceuticals/2020-08-12T08:48:35+01:00https://pharmamedic.co/news/general/an-independent-future-for-the-mhra/2020-09-09T09:09:37+01:00https://pharmamedic.co/resources/download-our-capabilities-brochure/2024-02-21T09:11:18+00:00https://pharmamedic.co/news/general/pmc-sponsor-pmea-2020-awards-test/2020-11-26T15:02:55+00:00https://pharmamedic.co/news/general/building-a-brighter-future-for-rare-disease-patients/2021-03-08T12:44:40+00:00https://pharmamedic.co/news/general/client-qa-dr-kathrine-scott-gedeon-richter/2020-11-24T10:02:07+00:00https://pharmamedic.co/news/general/congratulations-to-takeda-uk-and-makara-health-on-their-recognition-at-the-pmea-awards/2020-11-30T10:02:30+00:00https://pharmamedic.co/news/general/pharmamedic-announces-virtual-breakfast-briefing-on-10th-february-2021/2021-03-08T12:34:30+00:00https://pharmamedic.co/news/general/year-end-round-up-your-favourite-pharmamedic-articles-of-2020/2021-03-08T12:37:16+00:00https://pharmamedic.co/news/general/london-bioscience-innovation-centre-lbic-five-years-on/2021-01-11T12:09:31+00:00https://pharmamedic.co/news/general/the-role-of-regulatory-affairs-in-enabling-innovation/2021-01-26T08:59:54+00:00https://pharmamedic.co/news/general/key-takeaways-from-our-first-breakfast-briefing-february-2021/2021-03-08T12:36:34+00:00https://pharmamedic.co/news/general/3-ways-medical-affairs-consultants-added-value-during-the-covid-19-crisis/2021-03-17T10:24:47+00:00https://pharmamedic.co/news/general/pharmamedic-announces-2nd-virtual-breakfast-briefing-for-consultants-on-22nd-april-2021/2021-03-31T19:40:46+01:00https://pharmamedic.co/news/general/how-is-real-world-evidence-transforming-the-drug-development-paradigm/2021-04-15T08:46:49+01:00https://pharmamedic.co/news/general/pharmamedic-announces-session-sponsor-at-the-abpi-annual-conference-2021/2021-04-21T13:57:06+01:00https://pharmamedic.co/news/general/key-takeaways-from-our-second-successful-pharmamedic-virtual-breakfast-briefing/2021-04-28T14:38:38+01:00https://pharmamedic.co/news/general/abpi-conference-provided-optimism-for-the-future-of-the-uk-as-a-life-sciences-superpower/2021-05-05T15:21:06+01:00https://pharmamedic.co/news/general/patients-and-pharma-stand-to-benefit-from-innovative-licensing-and-access-pathway-scheme/2021-05-25T11:17:47+01:00https://pharmamedic.co/news/general/implementing-patient-and-public-involvement-in-research-qa-with-dr-joanne-james/2021-06-23T09:14:27+01:00https://pharmamedic.co/news/general/pmc-announces-next-virtual-breakfast-briefing-discussing-the-role-of-public-private-collaborations/2021-07-01T17:14:57+01:00https://pharmamedic.co/news/general/pmc-shares-ilap-thought-leadership-in-lbics-summer-newsletter/2021-07-14T13:56:19+01:00https://pharmamedic.co/news/general/what-does-the-future-for-clinical-research-delivery-hold-in-the-uk/2021-07-07T13:37:54+01:00https://pharmamedic.co/news/general/the-role-of-public-private-collaborations-in-innovation-highlights-from-our-virtual-breakfast-briefing/2021-07-21T15:48:43+01:00https://pharmamedic.co/news/general/government-report-recommends-clinical-trial-and-digital-health-regulation-reform/2021-08-16T11:40:36+01:00https://pharmamedic.co/news/general/a-new-horizon-for-medical-devices-regulation-in-the-uk/2021-09-22T08:55:43+01:00https://pharmamedic.co/news/general/virtual-breakfast-briefing-shaping-the-uks-position-in-the-international-community-innovation-and-regulatory-perspectives/2021-10-06T16:55:13+01:00https://pharmamedic.co/news/general/how-do-we-shape-our-professional-development-as-consultants/2021-10-19T09:09:59+01:00https://pharmamedic.co/news/takeaways-from-our-latest-virtual-breakfast-briefing-shaping-the-uks-position-in-the-international-community-innovation-and-regulatory-perspectives/2021-10-28T14:57:19+01:00https://pharmamedic.co/news/general/expecting-the-unexpected-managing-the-impact-of-lack-of-supplies-and-shortages-on-the-uk-pharmaceutical-sector/2021-11-18T14:15:55+00:00https://pharmamedic.co/resources/entering-the-uk-life-science-sector/2021-12-13T14:57:46+00:00https://pharmamedic.co/news/pharmamedic-features-in-the-lbic-winter-newsletter-with-insights-on-regulatory-innovation/2021-12-07T15:47:56+00:00https://pharmamedic.co/news/targeted-approaches-to-development-and-commercialisation-trends-for-2022/2022-01-31T09:56:47+00:00https://pharmamedic.co/news/general/join-our-virtual-breakfast-briefing-medical-affairs-in-2022-business-as-usual-or-a-reshaped-environment/2022-02-03T09:23:22+00:00https://pharmamedic.co/news/general/how-jp-morgan-healthcare-trends-inform-pharma-mood-music-for-2022/2022-02-15T15:09:25+00:00https://pharmamedic.co/news/general/breakfast-briefing-takeaways-medical-affairs-in-2022-business-as-usual-or-a-reshaped-environment/2022-03-01T08:51:38+00:00https://pharmamedic.co/news/general/the-value-of-a-pharmaceutical-physician-as-a-non-executive-director/2022-03-22T11:33:30+00:00https://pharmamedic.co/news/general/join-our-free-webinar-medical-affairs-3-0-a-discipline-comes-of-age-focus-on-evidence-generation-dissemination-for-strategic-impact/2022-03-29T09:34:41+01:00https://pharmamedic.co/news/general/living-with-covid-the-role-of-antivirals/2022-04-06T16:56:55+01:00https://pharmamedic.co/news/takeaways-from-our-april-breakfast-briefing-medical-affairs-3-0-a-discipline-comes-of-age/2022-05-03T14:13:52+01:00https://pharmamedic.co/news/whats-trending-in-regulatory-affairs-pharmamedic-in-discussion-with-dr-zubair-hussain/2022-06-07T10:30:41+01:00https://pharmamedic.co/news/general/join-our-free-webinar-beyond-the-numbers-strategic-partnering-with-your-statistical-colleagues/2022-06-01T16:15:32+01:00https://pharmamedic.co/news/general/embracing-a-digital-healthcare-future/2022-06-29T12:00:25+01:00https://pharmamedic.co/news/breakfast-briefing-takeaways-beyond-the-numbers-strategic-partnering-with-your-statistical-colleagues/2022-07-03T20:14:44+01:00https://pharmamedic.co/news/the-cro-as-strategic-partner/2022-08-10T13:29:29+01:00https://pharmamedic.co/news/general/abpi-report-warns-uk-is-losing-its-global-standing-in-clinical-trials/2022-11-08T14:52:47+00:00https://pharmamedic.co/news/ema-and-hma-open-big-data-regulatory-documents-to-public-consultation/2022-11-01T14:42:19+00:00https://pharmamedic.co/news/trade-bodies-unite-to-support-better-access-to-vaccines-for-future-pandemics/2022-11-08T14:49:27+00:00https://pharmamedic.co/news/general/nice-develops-proportionate-approach-to-technology-appraisals/2022-11-08T14:50:41+00:00https://pharmamedic.co/news/general/mhra-and-nice-get-wellcome-funding-for-regulation-of-mental-health-products/2022-11-08T14:49:04+00:00https://pharmamedic.co/news/general/mhra-fast-tracks-pill-to-prevent-pre-eclampsia/2022-11-09T09:45:00+00:00https://pharmamedic.co/news/general/trends-affecting-pharmacovigilance/2022-11-21T11:20:56+00:00https://pharmamedic.co/news/general/mhra-postpones-implementation-of-medical-device-regulations/2022-11-14T13:36:59+00:00https://pharmamedic.co/news/general/european-unions-share-of-global-medicine-rd-shrinks-by-25-in-20-years/2022-11-25T13:32:16+00:00https://pharmamedic.co/news/uk-autumn-statement-to-review-life-sciences-regulation/2022-11-22T10:14:49+00:00https://pharmamedic.co/news/general/uk-government-introduces-vaccine-taskforce-model-to-tackle-four-health-challenges/2022-11-28T12:13:56+00:00https://pharmamedic.co/news/general/atmps-for-rare-diseases-a-priority-for-innovative-health-initiative-funding/2022-12-05T14:06:39+00:00https://pharmamedic.co/news/general/challenges-and-trends-in-medical-affairs/2022-11-30T12:04:13+00:00https://pharmamedic.co/news/general/uk-office-for-life-sciences-publishes-data-on-the-sector/2022-12-08T16:53:44+00:00https://pharmamedic.co/news/general/european-council-backs-delay-to-medical-devices-regulation-mdr-deadlines/2022-12-12T15:56:13+00:00https://pharmamedic.co/news/general/uk-mhra-updates-how-to-report-medical-device-vigilance/2022-12-14T13:54:12+00:00https://pharmamedic.co/news/medical-affairs-outsourcing-trends-and-benefits/2022-12-19T14:41:52+00:00https://pharmamedic.co/news/general/abpi-asks-uk-government-to-review-vpas-as-clawback-will-hit-26-5-of-sales-revenue-in-2023/2022-12-19T16:37:07+00:00https://pharmamedic.co/news/general/amgen-strengthens-rare-disease-drug-portfolio-with-purchase-of-horizon/2022-12-20T12:25:11+00:00https://pharmamedic.co/news/general/uk-government-commits-over-175-million-to-genomics-research/2022-12-20T12:25:38+00:00https://pharmamedic.co/news/general/ema-and-ecdc-collaborate-on-vaccine-safety-and-effectiveness-monitoring-studies/2022-12-20T12:26:34+00:00https://pharmamedic.co/news/general/ohe-innovation-policy-prize/2023-01-05T13:39:53+00:00https://pharmamedic.co/news/general/ema-reminder-that-clinical-trials-must-use-ctis/2023-01-09T16:22:51+00:00https://pharmamedic.co/news/general/bia-reassured-by-chancellor-on-life-science-support/2023-01-12T13:41:39+00:00https://pharmamedic.co/news/general/ich-webinar-to-update-on-m11-clinical-trial-guideline/2023-01-17T10:14:40+00:00https://pharmamedic.co/news/general/ec-adopts-proposal-to-allow-more-time-to-certify-medical-devices/2023-01-23T10:12:15+00:00https://pharmamedic.co/news/general/mhra-ramps-up-assessment-capacity-for-in-vitro-diagnostic-devices/2023-01-30T15:22:28+00:00https://pharmamedic.co/news/general/jp-morgan-healthcare-conference-research-trends-in-2023/2023-01-25T13:16:37+00:00https://pharmamedic.co/news/general/pharma-deals-at-41st-jp-morgan-healthcare-conference/2023-02-01T10:47:50+00:00https://pharmamedic.co/news/join-our-free-breakfast-briefing-quality-systems-in-pharma-who-what-when/2023-02-07T09:11:50+00:00https://pharmamedic.co/news/general/uk-leads-on-new-regulatory-framework-for-point-of-care-medicine-manufacturing/2023-02-06T17:23:28+00:00https://pharmamedic.co/news/general/mhra-announces-new-international-recognition-framework-for-mas-from-2024/2023-02-09T16:21:09+00:00https://pharmamedic.co/news/general/uk-government-publishes-response-to-mhra-fee-consultation/2023-02-13T15:43:12+00:00https://pharmamedic.co/news/general/medical-technology-strategy-launched-by-uk-government/2023-02-16T12:03:18+00:00https://pharmamedic.co/news/general/prof-asif-ahmed-guest-speaker-at-pharmamedic-consultancy-event/2023-02-14T15:08:40+00:00https://pharmamedic.co/news/general/thanks-to-our-guest-speaker-prof-asif-ahmed/2023-02-20T13:45:42+00:00https://pharmamedic.co/news/general/advances-in-rare-disease-diagnosis/2023-02-28T11:46:54+00:00https://pharmamedic.co/news/general/ema-publishes-overview-of-medicines-recommended-in-2022/2023-02-21T15:01:25+00:00https://pharmamedic.co/news/general/european-parliament-adopts-extension-to-mdr-transition-period/2023-02-23T13:25:00+00:00https://pharmamedic.co/news/general/breakfast-briefing-takeaways-quality-systems-in-pharma-who-what-when/2023-02-27T13:42:14+00:00https://pharmamedic.co/news/general/government-publishes-englands-rare-diseases-priorities-for-2023/2023-03-06T15:48:39+00:00https://pharmamedic.co/news/general/government-confirms-increase-to-pharmas-statutory-scheme/2023-03-09T14:28:00+00:00https://pharmamedic.co/news/general/windsor-framework-returns-ni-medicines-control-to-uk/2023-03-20T10:07:17+00:00https://pharmamedic.co/news/general/silicon-valley-bank-uk-tech-companies-rescued-by-hsbc/2023-03-13T15:07:28+00:00https://pharmamedic.co/news/general/uk-government-launches-science-and-technology-framework/2023-03-16T15:56:38+00:00https://pharmamedic.co/news/general/support-for-life-sciences-in-uk-spring-budget-2023/2023-03-22T11:11:25+00:00https://pharmamedic.co/news/join-our-free-breakfast-briefing-so-you-want-to-be-a-pharma-consultant-company-structure-and-insurance-implications/2023-03-22T16:21:33+00:00https://pharmamedic.co/news/general/current-ir35-rules-and-how-they-affect-consultants/2023-03-28T12:37:31+01:00https://pharmamedic.co/news/general/report-says-inclusivity-and-diversity-vital-for-uk-clinical-trials/2023-04-04T11:12:35+01:00https://pharmamedic.co/news/general/uk-government-responds-to-consultation-on-clinical-trial-legislation/2023-04-06T15:20:41+01:00https://pharmamedic.co/news/general/efpia-director-general-calls-for-action-on-pharma-legislation/2023-04-11T10:56:36+01:00https://pharmamedic.co/news/general/pioneer-plan-to-support-uk-research-if-horizon-europe-talks-fail/2023-04-13T14:07:34+01:00https://pharmamedic.co/news/general/mhra-publishes-guidance-on-software-and-ai-as-a-medical-device/2023-04-20T15:41:16+01:00https://pharmamedic.co/news/general/bia-calls-on-nice-to-update-evidence-on-rare-disease-medicines/2023-04-20T15:39:26+01:00https://pharmamedic.co/news/general/breakfast-briefing-takeaways-so-you-want-to-be-a-pharma-consultant/2023-04-25T12:05:38+01:00https://pharmamedic.co/news/general/backing-innovation-in-british-biotechnology/2023-05-02T09:33:22+01:00https://pharmamedic.co/news/general/bia-launches-latest-biotech-financing-report/2023-05-03T13:58:58+01:00https://pharmamedic.co/news/general/nice-extends-international-collaboration-to-streamline-processes/2023-05-04T14:03:08+01:00https://pharmamedic.co/news/general/the-2023-abpi-annual-conference-focused-on-growing-the-life-sciences/2023-05-09T11:28:38+01:00https://pharmamedic.co/news/general/ecs-plans-for-updating-pharma-legislation-unveiled/2023-05-11T15:00:45+01:00https://pharmamedic.co/news/general/will-abpis-ambitious-vpag-plans-succeed-vpas/2023-05-15T14:59:52+01:00https://pharmamedic.co/news/general/new-integrated-pathology-unit-to-speed-cancer-diagnosis/2023-05-17T12:43:21+01:00https://pharmamedic.co/news/general/us-fda-issues-draft-guidance-on-decentralised-clinical-trials/2023-05-18T10:12:30+01:00https://pharmamedic.co/news/general/ema-annual-report-reviews-actions-in-2022/2023-05-24T15:18:01+01:00https://pharmamedic.co/news/general/developments-in-uk-mental-health-treatments/2023-05-23T09:12:59+01:00https://pharmamedic.co/news/general/award-for-pharmamedics-managing-director/2023-06-01T12:05:14+01:00https://pharmamedic.co/news/general/uk-life-sciences-get-650-million-growth-package/2023-06-05T13:58:30+01:00https://pharmamedic.co/news/general/mhra-announces-international-partnerships-to-accelerate-medicines-approvals/2023-06-08T15:08:12+01:00https://pharmamedic.co/news/general/uks-pro-innovation-regulation-of-technologies-review-life-sciences-report-outlines-regulatory-opportunities-to-speed-market-access/2023-06-07T15:24:06+01:00https://pharmamedic.co/news/general/abpi-report-highlights-skills-gaps/2023-06-12T11:56:16+01:00https://pharmamedic.co/news/general/mhra-consults-public-on-ich-good-clinical-practice-guideline/2023-06-15T16:56:31+01:00https://pharmamedic.co/news/general/windsor-framework-measures-start-1-january-2025/2023-06-19T13:00:57+01:00https://pharmamedic.co/news/general/new-drug-costs-threaten-nhs-financial-stability-says-report/2023-06-21T14:30:36+01:00https://pharmamedic.co/news/general/the-oshaughnessy-report-how-to-boost-clinical-trials-in-the-uk/2023-06-26T14:56:26+01:00https://pharmamedic.co/news/general/efpia-calls-for-revisions-to-pharmaceutical-regulation/2023-06-28T12:30:21+01:00https://pharmamedic.co/news/general/who-lists-research-priorities-on-antimicrobial-resistance/2023-06-29T16:13:18+01:00https://pharmamedic.co/news/general/pharma-conference-examines-mhra-vpas-staffing-and-real-estate-needs/2023-07-04T10:17:35+01:00https://pharmamedic.co/news/why-we-need-medical-affairs-3-0/2023-07-24T16:54:45+01:00https://pharmamedic.co/news/general/nice-invites-feedback-on-health-technology-evaluations-manual/2023-07-11T11:03:06+01:00https://pharmamedic.co/news/general/nihr-and-mrc-launch-uk-rare-disease-research-platform/2023-07-13T09:03:09+01:00https://pharmamedic.co/news/general/mhra-announces-corporate-plan-for-2023-2026/2023-07-17T09:45:25+01:00https://pharmamedic.co/news/general/international-investment-in-uk-life-sciences-plummets/2023-07-19T09:56:30+01:00https://pharmamedic.co/news/general/pharma-organisations-tussle-over-vpas-negotiations/2023-07-20T09:16:30+01:00https://pharmamedic.co/news/general/mhra-publishes-annual-report-for-2022-2023/2023-07-31T14:03:00+01:00https://pharmamedic.co/news/general/uk-government-consults-on-draft-legislation-on-merged-rd-tax-relief/2023-07-25T17:28:36+01:00https://pharmamedic.co/news/calling-biotech-startups/2023-08-02T15:15:07+01:00https://pharmamedic.co/news/general/clarification-on-continuation-of-ce-marking-in-uk/2023-08-07T15:53:39+01:00https://pharmamedic.co/news/general/still-no-uk-eu-agreement-on-horizon-europe/2023-08-16T11:33:48+01:00https://pharmamedic.co/news/general/differentiating-generics-in-a-crowded-marketplace/2024-02-20T15:43:25+00:00https://pharmamedic.co/news/general/mhra-consults-on-ending-ec-decision-reliance-procedure/2023-09-04T15:36:59+01:00https://pharmamedic.co/news/general/public-and-hcp-trust-in-uk-pharma-industry-maintained/2023-09-07T13:26:58+01:00https://pharmamedic.co/news/general/uk-rejoins-horizon-europe/2023-09-11T10:31:52+01:00https://pharmamedic.co/news/general/government-funds-to-grow-uk-life-sciences-workforce-and-upgrade-science-facility/2023-09-13T08:50:17+01:00https://pharmamedic.co/news/general/uks-mrc-invests-in-research-into-hard-to-treat-cancers/2023-09-18T15:05:37+01:00https://pharmamedic.co/news/join-our-free-breakfast-briefing-how-will-artificial-intelligence-and-machine-learning-impact-the-pharma-regulatory-and-medical-affairs-space/2024-03-05T16:50:03+00:00https://pharmamedic.co/news/general/breakfast-briefing-takeaways-how-will-artificial-intelligence-and-machine-learning-impact-the-pharma-regulatory-and-medical-affairs-space/2024-05-01T09:00:09+01:00https://pharmamedic.co/news/general/windsor-framework-updates-uk-medicine-laws/2024-09-25T10:27:31+01:00https://pharmamedic.co/news/medical-affairs-shaping-the-future-of-pharma-and-biotech/2024-10-09T15:33:34+01:00https://pharmamedic.co/news/general/driving-better-health-how-nhs-industry-partnerships-are-transforming-patient-care/2024-10-14T13:44:14+01:00https://pharmamedic.co/news/general/the-future-of-clinical-trials-whos-plan-to-improve-access-and-impact-worldwide/2024-10-16T15:18:24+01:00https://pharmamedic.co/news/general/bbsrc-invests-4m-to-spark-innovation-in-bioscience-with-23-new-projects/2024-10-17T12:04:58+01:00https://pharmamedic.co/news/how-to-drive-patient-impact-five-strategic-priorities-for-medical-affairs/2024-10-30T13:46:51+00:00https://pharmamedic.co/news/general/maximise-success-for-generic-manufacturers/2024-10-30T13:39:46+00:00https://pharmamedic.co/news/general/how-omnichannel-kol-engagement-drives-successful-medical-interactions/2024-11-04T13:50:13+00:00https://pharmamedic.co/news/general/groundbreaking-21-9m-uk-platform-launched-to-advance-cancer-immunotherapy/2024-11-07T11:59:13+00:00https://pharmamedic.co/news/from-support-to-strategy-how-medical-affairs-drives-smarter-drug-development/2024-11-11T12:58:56+00:00https://pharmamedic.co/news/general/think-differently-a-new-approach-to-transforming-medical-affairs-in-big-pharma/2024-11-14T11:33:29+00:00https://pharmamedic.co/news/how-digital-opinion-leaders-are-shaping-the-future-of-medical-affairs/2024-11-18T12:24:14+00:00https://pharmamedic.co/news/general/cut-through-the-noise-elevate-your-medical-affairs-strategy/2024-11-25T13:09:06+00:00https://pharmamedic.co/news/general/building-better-care-nhs-and-life-sciences-partnerships/2024-11-28T11:16:11+00:00https://pharmamedic.co/news/general/5-trends-shaping-medical-affairs-in-2025-are-you-ready/2024-12-02T12:48:34+00:00https://pharmamedic.co/news/general/unlocking-the-power-of-uk-health-data-to-transform-lives/2024-12-06T12:45:24+00:00https://pharmamedic.co/news/general/opportunity-admin-and-marketing-role/2025-05-27T15:45:09+01:00https://pharmamedic.co/news/general/pharmamedic-consultancy-celebrates-15-years-of-excellence/2025-10-21T13:33:17+01:00https://pharmamedic.co/news/general/3790/2025-10-16T15:40:06+01:00https://pharmamedic.co/news/calling-all-pharma-and-biotech-lets-partner-for-success/2025-10-29T15:38:31+00:00https://pharmamedic.co/news/general/pmc-strengthens-collaboration-with-healthcare-communication-agencies/2026-01-29T13:37:28+00:00https://pharmamedic.co/news/life-sciences-in-2026-7-trends-shaping-strategy/2026-03-02T14:54:21+00:00https://pharmamedic.co/news/general/pharmamedic-announces-expanded-medical-affairs-solutions-to-boost-branded-sales-from-existing-generic-portfolios/2026-06-18T11:34:41+01:00https://pharmamedic.co/news/leading-under-pressure-uk-pharma-in-an-ai-accelerated-era-industry-leaders-gather-for-a-pharmamedic-forum-in-collaboration-with-impactful-authenticity/2026-07-21T12:03:18+01:00https://pharmamedic.co/news/general/2-billion-returns-to-the-uk-what-the-abpis-competitiveness-report-means-for-investment-decisions/2026-09-09T11:06:49+01:00